Articles with "toceranib phosphate" as a keyword



Pancreatic adenocarcinoma treated with surgical resection, toceranib phosphate and firocoxib in a dog: a case report

Sign Up to like & get
recommendations!
Published in 2024 at "Veterinary Research Communications"

DOI: 10.1007/s11259-024-10349-5

Abstract: Exocrine pancreatic carcinomas are rarely reported in dogs. A ductal pancreatic adenocarcinoma in a 10-year-old intact beagle is described in this report. The diagnosis was made based on clinical signs, imaging (abdominal ultrasound and CT… read more here.

Keywords: toceranib phosphate; firocoxib; report; pancreatic adenocarcinoma ... See more keywords

Assessment of postoperative adjuvant treatment using toceranib phosphate against adenocarcinoma in dogs

Sign Up to like & get
recommendations!
Published in 2020 at "Journal of Veterinary Internal Medicine"

DOI: 10.1111/jvim.15768

Abstract: Abstract Background Toceranib phosphate (TOC) could be made widely available for treating tumors in dogs if evidence shows that TOC inhibits recurrence after surgery. Objectives To investigate how postoperative adjuvant treatment with TOC modulates the… read more here.

Keywords: surgery; postoperative adjuvant; adjuvant treatment; treated surgery ... See more keywords

Discovery of canine drug toceranib phosphate as a repurposed agent against human hepatocellular carcinoma

Sign Up to like & get
recommendations!
Published in 2022 at "Liver International"

DOI: 10.1111/liv.15540

Abstract: Human hepatocellular carcinoma (HCC) is an aggressive malignancy with poor clinical outcomes. There are limited therapeutic options for those diagnosed with terminal HCC and therefore incorporating novel agents into standard‐of‐care regimens is urgently needed. In… read more here.

Keywords: hepatocellular carcinoma; human hepatocellular; toceranib phosphate; drug ... See more keywords

Response and outcome following toceranib phosphate treatment for stage four anal sac apocrine gland adenocarcinoma in dogs: 15 cases (2013-2017).

Sign Up to like & get
recommendations!
Published in 2019 at "Journal of the American Veterinary Medical Association"

DOI: 10.2460/javma.254.8.960

Abstract: OBJECTIVE To assess response and outcome in dogs with stage 4 anal sac apocrine gland adenocarcinoma (ASAGA) treated with toceranib phosphate as the sole chemotherapeutic agent. DESIGN Retrospective case series. ANIMALS 15 client-owned dogs with… read more here.

Keywords: stage; response; treatment; anal sac ... See more keywords